As the world’s only formulation of long-acting goserelin microspheres approved for launch in China, Baituowei was developed by the company’s world-leading R&D platform for long-acting and extended release drug delivery technology.

China’s first class 1 innovative chemical drug independently developed locally for the treatment of major depressive disorder and protected by intellectual property rights.

Specification：0.3g
Indication：Hyperlipidemia

Specification：30mg,60mg
Indication：For heart failure, myocarditis, sick sinus syndrome, coronary heart disease and cardiomyopathy

Specification：40mg
Indication：Essential hypertension

Specification：50mg
Indication：(1)Type Ⅱ diabetes,(2)Reduce postprandial blood sugar of impaired glucose tolerance

Specification：30mg
Indication：Type Ⅱ diabetes

Specification：1.45g
Indication：Hypokalemia

Specification：5mg
Indication：Primary parkinsonism

Approved for marketing in the U.S. for the treatment of schizophrenia in adults and as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder in adults.




Approved for marketing in China for the treatment of acute and chronic schizophrenia, the significant positive and negative symptoms of various other psychotic states, and for the alleviation of the affective symptoms associated with schizophrenia.

Specification：4.6mg,9.5mg
Indication：Mild to moderate Alzheimer's disease

Specification：40mg,60mg,80mg
Indication：Suitable for acute upper gastrointestinal bleeding such as duodenal ulcer,gastric ulcer,acute gastric mucosal disease,compound gastric ulcer,etc.

Specification：40mg
Indication：Active peptic ulcer (gastric, duodenal ulcer),reflux esophagitis and Zollinger -Ehrlich syndrome

Specification：3g/bag
Indication：Acute and chronic diarrhea in adults and children

Specification：1g/tablet
Indication：Acute and chronic diarrhea in adults and children

Specification：0.3g,0.6g,1.2g,1.8g
Indication：the adjuvant treatment of liver damage caused by alcohol,viruses,drugs and other chemical substances.

Specification：5mg, 10mg,15mg
Indication：Swelling due to brain edema,trauma or surgery

Specification：30mg
Indication：Soft tissue swelling,venous edema

Specification：20g/tube
Indication：Local s welling ca used by inf lammation,degenerative d isease an d tra uma

Specification：1ml: 10 IU
Indication：Osteoporosis

Specification：7.5mg
Indication：Rheumatoid a rthritis, pa inful os teoarthritis

Specification：240mg
Indication：Osteoarthritis

Specification：10mg
Indication：Allergic rhinitis,allergic skin disease

Specification：25kg
Indication：Acute and chronic diarrhea

Specification：40kg
Indication：Hyperlipidemia

Specification：40kg
Indication：Hyperlipidemia

Specification：30mg
Indication：For chemotherapy of ovarian cancer,breast cancer,and NSCLC

Specification：0.25g,0.6g
Indication：Increase the sensitivity of tumor cells to radiotherapy and improve the effect of radiotherapy

Specification：1mg
Indication：Immunomodulators to enhance the immunity of patients

Specification：0.5g
Indication：Protect cells to reduce radiation damage